financetom
Business
financetom
/
Business
/
BRIEF-Arthur J. Gallagher & Co. Acquires W K Webster & Co Ltd
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Arthur J. Gallagher & Co. Acquires W K Webster & Co Ltd
Feb 3, 2025 12:32 AM

Feb 3 (Reuters) - Arthur J. Gallagher & Co. ( AJG ):

* ARTHUR J. GALLAGHER & CO. ( AJG ) ACQUIRES W K WEBSTER & CO LTD

* ARTHUR J. GALLAGHER & CO. ( AJG ): TERMS OF TRANSACTION WERE NOT

DISCLOSED.

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Sep 21, 2024
(Reuters) - Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will very likely be on the U.S. government's 2027 list of price negotiations, Bloomberg News reported on Tuesday citing a company executive. Part of 2022's Inflation Reduction Act allows Medicare to negotiate prices for prescription drugs that had been particularly expensive for the federal health program which covers millions...
SRIVARU Holding Gets Nasdaq Extension to Regain Compliance With Listing Standards; Shares Rise Pre-Bell
SRIVARU Holding Gets Nasdaq Extension to Regain Compliance With Listing Standards; Shares Rise Pre-Bell
Sep 21, 2024
05:16 AM EDT, 09/20/2024 (MT Newswires) -- SRIVARU Holding ( SVMH ) said Thursday that a Nasdaq hearings panel granted its request for continued listing, giving it the necessary time to implement its plan to regain compliance. The company said that if it can demonstrate compliance with the stockholders' equity standard by Nov. 14 then the panel will grant additional...
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Sep 21, 2024
Sept 17 (Reuters) - Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will very likely be on the U.S. government's 2027 list of price negotiations, Bloomberg News reported on Tuesday citing a company executive. Part of 2022's Inflation Reduction Act allows Medicare to negotiate prices for prescription drugs that had been particularly expensive for the federal health program which...
Nouveau Monde Graphite Gearing Up for Construction of the Phase-2 Matawinie Mine
Nouveau Monde Graphite Gearing Up for Construction of the Phase-2 Matawinie Mine
Sep 21, 2024
07:49 AM EDT, 09/20/2024 (MT Newswires) -- Nouveau Monde Graphite ( NMG ) said Friday that it has attained tangible milestones in preparing for the construction of the Phase-2 Matawinie Mine. The company has awarded the 120kV electrical substation to ABB contract to supply, construct and commission the 120kV substation for the Phase-2 Matawinie Mine. The site will be connected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved